---
updated: 2024-12-24 21:15
---
# è¬›ç¾©ä¸­é¡Œç›®
> 113-2 è—¥å¸«(4)  
	ä¸‹åˆ—æŠ—ç”Ÿç´ ä¸­ï¼Œä½•è€…ä¸æœƒç¶“ç”±è‚è‡Ÿä»£è¬ï¼Ÿ  
A. Isoniazid  
B. netilmicin  
C. chloramphenicol  
D. moxifloxacin  
?  
B  
ç­”æ¡ˆï¼š(B)Â netilmicinï¼šç”±è…æ’é™¤
(C) chloramphenicolï¼šç”±è‚æ’é™¤â†’ C3-glucuronide
(D) moxifloxacinï¼šç”±è‚æ’é™¤

----

> 113-2 è—¥å¸«  (5)
	æœ‰é—œæŠ—ç”Ÿç´  aminoglycosides è—¥ç‰©ä¹‹æ•˜è¿°ï¼Œä¸‹åˆ—ä½•è€…éŒ¯èª¤ï¼Ÿ  
A. å°æ–¼æ ¼è˜­æ°é™°æ€§å¥½æ°§èŒï¼ˆGram-negative aerobesï¼‰æŠ—èŒæ•ˆæœå¥½  
B. ä½µç”¨ furosemide æœƒåŠ é‡æ­¤é¡è—¥ç‰©ä¹‹è…è‡Ÿæ¯’æ€§  
C. å°æ–¼ tobramycin ç”¢ç”ŸæŠ—è—¥æ€§ä¹‹æ ¼è˜­æ°é™°æ€§èŒï¼Œå¯æ”¹ç”¨ amikacin æ²»ç™‚  
D. å…·æ™‚é–“ä¾è³´å‹ä¹‹æ®ºèŒä½œç”¨ï¼ˆtime-dependent killingï¼‰  
?  
D  


---

> 111-1 è—¥å¸«  (10)
	ä¸‹åˆ—é‚£ä¸€çµ„æŠ—ç”Ÿç´ ä½µç”¨æ™‚ï¼Œ(a)è—¥ç‰©å¯ä»¥å¢åŠ (b)è—¥ç‰©é€²å…¥ç´°èŒç´°èƒå…§çš„æ¿ƒåº¦ï¼Œå› è€Œç”¢ç”ŸæŠ‘èŒå”åŒä½œç”¨ï¼š  
A. (a) sulbactamï¼›(b) ampicillin  
B. (a) imipenemï¼›(b) cilastatin  
C. (a) sulfamethoxazoleï¼›(b) trimethoprim  
D. (a) ticarcillinï¼›(b) kanamycin  
?  
D  

---

> 110-1 è—¥å¸« (5)
	æœ‰é—œ aminoglycosides é¡æŠ—ç”Ÿç´ æŠ—è—¥æ€§ä¹‹æ•˜è¿°ï¼Œä¸‹åˆ—ä½•è€…æ­£ç¢ºï¼Ÿ  
A. gentamicin å°éˆçƒèŒåŠè…¸çƒèŒæ•ˆç”¨è¼ƒå·®ä¸»è¦æ˜¯å› ç‚ºå°ç´°èŒæ ¸ç³–é«”ä½œç”¨å·®  
B. vancomycin å¯ä»¥ä¿ƒé€² gentamicin æ•ˆç”¨æ˜¯å› ç‚ºå¢é€² gentamicin åœ¨ç´°èŒä¸­çš„è—¥ç‰©æ”å–é‡  
C. å° streptomycin å·²ç”¢ç”ŸæŠ—è—¥æ€§çš„çµæ ¸åˆ†ææ¡¿èŒé€šå¸¸ä¹Ÿå° amikacin æœ‰äº¤äº’æŠ—è—¥æ€§  
D. è‹¥ç”¢ç”Ÿ kanamycin èˆ‡ neomycin äº¤äº’æŠ—è—¥æ€§ï¼Œä¸¦ä¸æœƒé€²ä¸€æ­¥å°è‡´å° amikacin çš„æŠ—è—¥æ€§ç”¢ç”Ÿ  
?  
B
- A - å°éˆçƒèŒåŠè…¸çƒèŒæ•ˆç”¨è¼ƒå·®ä¸»è¦æ˜¯å› ç‚ºå°å­æ°§ç’°å¢ƒå·® (å› éœ€è¦O$_2$ é€²å…¥) 

---

> 109-1 è—¥å¸«  (5)
	æœ‰é—œ aminoglycosides é¡æŠ—ç”Ÿç´ ä¹‹æ•˜è¿°ï¼Œä¸‹åˆ—ä½•è€…éŒ¯èª¤ï¼Ÿ  
A. åœ¨é¹¼æ€§ç’°å¢ƒä¸­æ•ˆç”¨è¼ƒå¼·  
B. å¯ä»¥èˆ‡ Î²-lactam é¡æŠ—ç”Ÿç´ ä¸€èµ·ä½µç”¨æ–¼å°é©è˜­æ°é™°æ€§èˆ‡é™½æ€§èŒæŠ—è—¥æ€§èŒæ ª  
	C. streptomycinã€kanamycinã€gentamicinã€azithromycin çš†å±¬ aminoglycosides å¯ä»¥æŠ‘åˆ¶ç´°èŒè›‹ç™½è³ªç”Ÿæˆ  
D. èˆ‡ tetracyclines ä¸€æ¨£å¯æŠ‘åˆ¶è›‹ç™½è³ªç”Ÿæˆï¼Œçš†ä½œç”¨åœ¨ 30S è€Œé 50S æ ¸ç³–é«” RNA  
?  
C  

---

> 107-2 è—¥å¸«  (7) (è¤‡é¸é¡Œ)
	æœ‰é—œ aminoglycosides é¡æŠ—ç”Ÿç´ ä¹‹æ•˜è¿°ï¼Œä¸‹åˆ—ä½•è€…æ­£ç¢ºï¼Ÿ  
A. è‹¥å’Œåˆ©å°¿åŠ‘ Furosemide ä½µç”¨æ™‚å¯èƒ½åŠ é‡å…¶è…æ¯’æ€§  
B. ä¸»è¦ä»¥å£æœæ–¹å¼çµ¦è—¥æ²»ç™‚å…¨èº«æ€§æ„ŸæŸ“  
C. å¯ä»¥å’Œ Ticarcillin åˆä½µç”¨æ–¼æ²»ç™‚ç¶ è†¿æ¡¿èŒä¹‹æ„ŸæŸ“  
D. ä¸»è¦ç”±è‚è‡Ÿä»£è¬ä½¿å…¶å¤±å»è—¥æ•ˆ  
?  
**AC**

---

> 113-1 è—¥å¸«  (75)
	ä¸‹åˆ—å››ç’°ç´ ï¼ˆtetracyclinesï¼‰ï¼Œä½•è€…æœ€å¯èƒ½ç”¢ç”Ÿ Fanconi-like syndrome å‰¯ä½œç”¨ï¼Ÿ  
A. demeclocycline  
B. minocycline  
C. doxycycline  
D. tigecycline  
?  
A  

---

> 99-2 è—¥å¸«  (74)
	æœç”¨å››ç’°ç´ ï¼ˆtetracyclinesï¼‰è€…æ˜“ç”¢ç”Ÿ Fanconi-like syndromeï¼Œæ­¤ç¾è±¡ç‚ºä¸‹åˆ—é‚£ç¨®é™è§£ç”¢ç‰©æ‰€é€ æˆçš„ï¼Ÿ  
A. C-5a, 6-Anhydrotetracyclines  
B. 4-Epianhydrotetracyclines  
C. 4-Epitetracyclines  
D. Isotetracycline  
?  
B  
Fanconi syndrome æ˜¯ä¸€ç¨®è…è‡Ÿè¿‘æ›²å°ç®¡ç–¾ç—…ï¼Œç—‡ç‹€åŒ…æ‹¬å¤šå°¿å’Œè„«æ°´ã€‚Demeclocycline å¯ç”¨æ–¼æ²»ç™‚ SIADH (æŠ—åˆ©å°¿æ¿€ç´ åˆ†æ³Œéå¤šçš„ç–¾ç—…)ï¼Œä½†å…¶åˆ©å°¿ä½œç”¨å¯èƒ½å°è‡´ Fanconi-like syndromeã€‚C-6 ä¸Šé†‡åŸºè„«æ°´å¯å¼•èµ·è…æ¯’æ€§åŠ Fanconi-like syndromeã€‚

---

> 106-1 é†«å¸«  (60)
	é—œæ–¼ tetracyclines é¡æŠ—ç”Ÿç´ ä¹‹æ•˜è¿°ï¼Œä¸‹åˆ—ä½•è€…æ­£ç¢ºï¼Ÿ  
A. å¯çµåˆè‡³ç´°èŒä¹‹ 50S æ ¸é†£é«”ï¼Œè€Œå¹²æ“¾è›‹ç™½è³ªåˆæˆ  
B. å¸¸èˆ‡åˆ¶é…¸åŠ‘ä½µç”¨ï¼Œä»¥é é˜²èƒƒéƒ¨ä¸é©  
C. æ²»ç™‚ç«‹å…‹æ¬¡é«”æ„ŸæŸ“çš„é¦–é¸è—¥ç‰©  
D. Doxycycline å£æœæ™‚ï¼Œæ˜“å—é£Ÿç‰©å¹²æ“¾å¸æ”¶  
?  
C  

---

> 110-2 è—¥å¸«  (5)
	é—œæ–¼ erythromycin çš„æ•˜è¿°ï¼Œä¸‹åˆ—ä½•è€…éŒ¯èª¤ï¼Ÿ  
A. åœ¨é…¸æ€§ç’°å¢ƒä¸­èƒ½å¢åŠ å…¶è—¥æ•ˆ  
B. ç¶“ç”±çµåˆåˆ° 50S æ ¸ç³–é«” RNA é”åˆ°æŠ‘åˆ¶ç´°èŒç”Ÿå­˜  
C. å¯ä»¥æœ‰æ•ˆæŠ‘åˆ¶è‚ºç‚é»´æ¼¿èŒ  
D. å› ç‚ºæŠ‘åˆ¶ cytochrome P450 é…µç´ æ´»æ€§è€Œæœƒå¢åŠ  warfarin è¡€ä¸­æ¿ƒåº¦  
?  
A  

---

> 108-1 è—¥å¸«  (3)
	ç‚ºç¯©æª¢äººé«”å…§ä»£è¬é…µç´  CYP3A4 ä¹‹æ´»æ€§ï¼Œé¸ç”¨ä¸‹åˆ—ä½•ç¨®è—¥ç‰©ç•¶ä½œæŒ‡æ¨™æœ€é©ç•¶ï¼Ÿ  
A. Caffeine  
B. dextromethorphan  
C. erythromycin  
D. tolbutamide  
?  
C  

---

> 108-2 é†«å¸«  (2)
	ä¸‹åˆ—ä½•ç¨®è—¥ç‰©æœ€é©åˆæ²»ç™‚è‚ºç‚é»´æ¼¿èŒï¼ˆMycoplasma pneumoniaeï¼‰æ‰€å¼•èµ·ä¹‹è‚ºç‚ï¼Ÿ  
A. é’é»´ç´ ï¼ˆPenicillinï¼‰  
B. ç¢³é’é»´çƒ¯ï¼ˆCarbapenemï¼‰  
C. é ­å­¢å­ç´ ï¼ˆCephalosporinï¼‰  
D. ç´…é»´ç´ ï¼ˆErythromycinï¼‰  
?  
D  

---

> 108-1 é†«å¸«  (2)
	å°å—åˆ°ç¦½å‹åˆ†ææ¡¿èŒç¾¤ï¼ˆMycobacterium avium Complex, MACï¼‰æ„ŸæŸ“çš„ç—…æ‚£ï¼Œå»ºè­°ä½¿ç”¨ä¸‹åˆ—é‚£ç¨®è—¥ç‰©åˆä½µä¹™èƒºä¸é†‡ï¼ˆethambutolï¼‰åŠåˆ©ç¦å¸ƒä¸ï¼ˆrifabutinï¼‰é€²è¡Œæ²»ç™‚ï¼Ÿ  
A. é˜¿å¥‡é»´ç´ ï¼ˆazithromycinï¼‰  
B. ç¡åŸºç”²å˜§å”‘ä¹™é†‡ï¼ˆmetronidazoleï¼‰  
C. å…‹æ‹‰ç¶­é…¸ï¼ˆclavulanic acidï¼‰  
D. æ£˜ç™½èŒç´ ï¼ˆechinocandinï¼‰  
?  
A  

---

> 110-2 é†«å¸«  (54)
		é—œæ–¼æŠ‘åˆ¶ç´°èŒè›‹ç™½è³ªåˆæˆé¡çš„æŠ—ç”Ÿç´ æ‡‰ç”¨ï¼Œä¸‹åˆ—æ•˜è¿°ä½•è€…æ­£ç¢ºï¼Ÿ  
	A. Clindamycin å¯æŠ‘åˆ¶ç´°èŒè›‹ç™½è³ªåˆæˆï¼Œä¸¦å¯æ²»ç™‚å¤§éƒ¨åˆ†çš„é©è˜­æ°é™°æ€§å¥½æ°§èŒæ„ŸæŸ“  
	B. Clindamycin èƒ½èˆ‡ cephalosporin ä½µç”¨æ²»ç™‚éª¨ç›†è†¿ç˜åŠæµç”¢æ„ŸæŸ“  
	C. quinupristin-dalfopristin å¯ç”¨æ–¼æ²»ç™‚é©è˜­æ°é™½æ€§èŒèˆ‡å…·å…§æºæ€§æŠ—è—¥æ€§ä¹‹ç³è…¸çƒèŒï¼ˆE faecalisï¼‰æ„ŸæŸ“  
	D. Tedizolid å¯ç”¨æ–¼æ²»ç™‚é©è˜­æ°é™½æ€§èŒæ„ŸæŸ“ï¼Œä½†å°æ–¼æŠ—è—¥æ€§é‡‘é»ƒè‘¡è„çƒèŒï¼ˆmethicillin-resistant S aureusï¼‰ç„¡æ²»ç™‚æ•ˆç›Š  
?  
B  

---

> 109-1 é†«å¸«  (7)
	é—œæ–¼è‰±é›£æ¢­ç‹€èŠ½èƒæ¡¿èŒï¼ˆClostridium difficileï¼‰çš„æ•˜è¿°ï¼Œä¸‹åˆ—ä½•è€…æ­£ç¢ºï¼Ÿ  
A. ç–¾ç—…ç¶“å¸¸æ˜¯å› é•·æœŸä½¿ç”¨æŠ—ç”Ÿç´ ï¼Œé€ æˆè…¸é“èŒç¾¤æ”¹è®Šæ‰€å¼•èµ·  
B. å¯ç”¨å®‰æ¯”è¥¿æ—ï¼ˆampicillinï¼‰å’Œå…‹æ—é»´ç´ ï¼ˆclindamycinï¼‰æ²»ç™‚  
C. æœƒç”¢ç”Ÿè…¸æ¯’ç´ ï¼ˆenterotoxinï¼‰ï¼Œé€ æˆè‚Œè‚‰ç—™æ”£  
D. æœƒç”¢ç”ŸÎ±æ¯’ç´ ï¼ˆÎ± toxinï¼‰ï¼Œé€ æˆåš´é‡çš„è»Ÿçµ„ç¹”å£æ­»  
?  
A  

---

> 113-2 è—¥å¸«  (6)
	æŠ‘åˆ¶ç´°èŒæ ¸ç³–é«”çš„æŠ—ç”Ÿç´ èˆ‡æ©Ÿè½‰é…å°ï¼Œä¸‹åˆ—ä½•è€…æ­£ç¢ºï¼Ÿ  
A. Tetracycline å¯é€ æˆ misreading of mRNAï¼Œè€Œä½¿ç´°èŒåŠ å…¥éŒ¯èª¤èƒºåŸºé…¸ï¼Œç”Ÿæˆç„¡åŠŸèƒ½ä¹‹è›‹ç™½è³ª  
B. Lefamulin å¯æŠ‘åˆ¶ 70S ribosome ä¹‹ initiation complex ç”Ÿæˆ  
C. Erythromycin å¯æŠ‘åˆ¶ peptidyl transferase ä¹‹æ´»æ€§  
D. Chloramphenicol å¯æŠ‘åˆ¶ aminoacyl-tRNA çµåˆè‡³ mRNA ribosome complex  
?  
C

---

> 112-2 è—¥å¸«  (7)
	ä¸‹åˆ—æŠ—ç”Ÿç´ ä¸­ï¼Œä½•è€…æŠ—èŒæ©Ÿè½‰ä¸æ˜¯æŠ‘åˆ¶ç´°èŒä¹‹è›‹ç™½è³ªåˆæˆï¼Œä»¥é”åˆ° bacteriostatic æˆ– bactericidal effectsï¼Ÿ  
A. quinupristin-dalfopristin  
B. tedizolid  
C. tigecycline  
D. Fosfomycin  
?  
D  

---

> 109-2 è—¥å¸«  (74)
	æœ‰é—œ fidaxomicin çš„æ•˜è¿°ï¼Œä½•è€…éŒ¯èª¤ï¼Ÿ  
A. å±¬æ–¼å·¨å…§é…¯ï¼ˆmacrolidesï¼‰æŠ—ç”Ÿç´   
B. çµæ§‹ä¸­å«æœ‰ç³–åŸº  
C. å£æœå¸æ”¶è‰¯å¥½  
D. ç”¨æ–¼æ²»ç™‚å›°é›£æ¢­ç‹€èŠ½å­¢æ¡¿èŒï¼ˆC. difficileï¼‰æ„ŸæŸ“  
?  
C  

---

> 113-1 é†«å¸«  (9)
	ä¸‹åˆ—é‚£ä¸€ç¨®æŠ—ç”Ÿç´ ä¸»è¦ä¸æ˜¯ä½œç”¨æ–¼ç´°èŒç´°èƒå£ï¼Ÿ  
A. ç•°è¸é¹¼é†¯ï¼ˆisoniazidï¼‰  
B. ä¹™èƒºä¸é†‡ï¼ˆethambutolï¼‰  
C. åˆ©å¥ˆå”‘èƒºï¼ˆlinezolidï¼‰  
D. è¬å¤é»´ç´ ï¼ˆvancomycinï¼‰  
?  
C  

---

> 111-1 é†«å¸«  (4)
	ä¸‹åˆ—ä½•ç¨®æŠ—ç”Ÿç´ ä¸æ˜¯ç¶“ç”±æŠ‘åˆ¶ç´°èŒè›‹ç™½è³ªç”Ÿåˆæˆï¼Œé”åˆ°æŠ‘åˆ¶ç´°èŒç”Ÿé•·æˆ–æ®ºèŒä¹‹ä½œç”¨ï¼Ÿ  
A. å¡ç´é»´ç´ ï¼ˆkanamycinï¼‰  
B. å…‹æ—é»´ç´ ï¼ˆclindamycinï¼‰  
C. ç¡åŸºç”²å˜§å”‘ä¹™é†‡ï¼ˆmetronidazoleï¼‰  
D. å››ç’°ç´ ï¼ˆtetracyclineï¼‰  
?  
C  

---

> 106-2 é†«å¸«  (6) (è¤‡é¸é¡Œ)
	ä¸‹åˆ—é‚£ä¸€ç¨®æŠ—ç”Ÿç´ ï¼Œé©åˆç”¨ä¾†æ²»ç™‚å—œè‚ºæ€§é€€ä¼è»äººèŒï¼ˆLegionella pneumophilaï¼‰æ‰€å¼•èµ·çš„è‚ºç‚ï¼Ÿ  
A. å…‹æ—é”é»´ç´ ï¼ˆclindamycinï¼‰  
B. é˜¿å¥‡é»´ç´ ï¼ˆazithromycinï¼‰  
C. å®‰æ¯”è¥¿æ—ï¼ˆampicillinï¼‰  
D. å…©æ€§é»´ç´  Bï¼ˆamphotericin Bï¼‰  
?  
AB  

---

> 105-2 é†«å¸«  (52)
	ä¸‹åˆ—ä½•ç¨®è—¥ç‰©ä¸é©ç”¨æ–¼ vancomycin-resistant Enterococcus faecium ä¹‹æ„ŸæŸ“æ²»ç™‚ï¼Ÿ  
A. Linezolid  
B. tigecycline  
C. quinupristin-dalfopristin  
D. teicoplanin  
?  
D  
- ABç‚ºå¾Œç·šè—¥ç‰©
### Bacterial Protein Synthesis ç´°èŒè›‹ç™½è³ªçš„åˆæˆ
- **æ²‰é™ä¿‚æ•¸ (Svedberg unit, S)**: è›‹ç™½è³ªæˆ–RNAç‰‡æ®µåœ¨é›¢å¿ƒéç¨‹ä¸­çš„æ²‰é™é€Ÿåº¦ã€‚
-  70S æ ¸ç³–é«”ç”± 30S å’Œ 50S äºåŸºçµ„æˆã€‚

---

#### ä½œç”¨æ–¼ç´°èŒè›‹ç™½è³ªåˆæˆçš„æŠ—ç”Ÿç´ 

1. **Aminoglycosides**:
   - æŠ‘åˆ¶èµ·å§‹ï¼Œå°è‡´æ ¸ç³–é«”ç„¡æ³•æ²¿è‘— mRNA å‰é€²ã€‚
   - å¯èƒ½å°è‡´ mRNA éŒ¯è®€ä¸¦åŠ å…¥éŒ¯èª¤çš„èƒºåŸºé…¸ã€‚
2. **Tetracycline å’Œ Chloramphenicol**:
   - æŠ‘åˆ¶ tRNA èˆ‡ mRNA å¯†ç¢¼å­çš„çµåˆã€‚
   - **Linezolid**:
      - æŠ‘åˆ¶ 70S èµ·å§‹è¤‡åˆé«”çš„å½¢æˆã€‚


3. **Chloramphenicol å’Œ Erythromycin**:
   - æŠ‘åˆ¶è‚½éµçš„å½¢æˆã€‚
   - æŠ‘åˆ¶æ ¸ç³–é«”çš„ç§»ä½éç¨‹ã€‚
4. **Clindamycinã€Erythromycin å’Œ Ketolide**:
   - æŠ‘åˆ¶æ ¸ç³–é«”ç§»ä½ã€‚



---

#### èƒºåŸºé†£è‹·é¡ä½œç”¨æ–¼è›‹ç™½è³ªåˆæˆçš„å½±éŸ¿  
- æŠ‘åˆ¶èµ·å§‹ â†’ é€ æˆè›‹ç™½è³ªåˆæˆææ—©ä¸­æ­¢  
- å¯èƒ½å°è‡´éŒ¯èª¤çš„èƒºåŸºé…¸æ’å…¥  

---

# Aminoglycosides èƒºåŸºé†£è‹·é¡ (30S)

- å¸¸è¦‹è—¥ç‰©: **Streptomycin, Neomycin**, Kanamycin, **Amikacin, Gentamicin**, Tobramycin, Sisomicin, Netilmicin  
- ä½œç”¨æ©Ÿåˆ¶:  
  - é€šéå¤–è†œä¸Šçš„poriné€šé“è¢«å‹•æ“´æ•£é€²å…¥ç´°èƒ â†’ **ç¶“ç”±æ°§**ä¾è³´éç¨‹é€²ä¸€æ­¥ä¸»å‹•é‹è¼¸é€²å…¥ç´°èƒè³ª â†’ **çµåˆæ–¼30Sæ ¸ç³–é«”å–®ä½**ï¼ŒæŠ‘åˆ¶è›‹ç™½è³ªåˆæˆã€‚  
  - æŠ—èŒæ´»æ€§:  
    - **å°G(-)ç´°èŒå…·æœ‰è¼ƒå¼·ä½œç”¨**ï¼Œå°¤å…¶å°å¥½æ°§æ€§G(-)æ¡¿èŒæœ‰æ•ˆï¼Œ**ä½†å°å­æ°§æ€§G(-)ç„¡æ•ˆ**ã€‚(å› éœ€è¦O$_2$ é€²å…¥)  
    - å¸¸èˆ‡penicillinsæˆ–cephalosporinsä½µç”¨ï¼Œç”¨æ–¼æ²»ç™‚å¿ƒå…§è†œç‚å’Œå…¶ä»–ç¶ è†¿æ¡¿èŒç›¸é—œçš„åš´é‡å‘¼å¸é“æ„ŸæŸ“ã€‚  
    - ==**Amikacin** æ˜¯æœ€ä¸æ˜“ç”¢ç”ŸæŠ—è—¥æ€§çš„èƒºåŸºé†£è‹·é¡è—¥ç‰©ã€‚==  

> [!NOTE] é‡é»
> èƒºåŸºé†£è‹·é¡ä¸»è¦ä½œç”¨æ–¼30Sæ ¸ç³–é«”å–®ä½ä¸¦æŠ‘åˆ¶è›‹ç™½è³ªåˆæˆï¼Œèˆ‡å…¶ä»–æŠ—ç”Ÿç´ çš„ä½µç”¨åœ¨è‡¨åºŠä¸Šæœ‰ç‰¹æ®Šæ„ç¾©ã€‚


### Sites of Enzymatic Inactivation of Aminoglycosides
- **ç´°èŒä»£è¬é…¶çš„ä½œç”¨æ©Ÿåˆ¶**: ç´°èŒå¯èª˜ç™¼ç”Ÿæˆç‰¹å®šä»£è¬é…¶ä»¥ä½¿Aminoglycosideså»æ´»åŒ–ã€‚  
  - **ä¸»è¦ä»£è¬é…¶ç¨®é¡**:  
    - **Acetylase** (ä¹™é†¯åŒ–é…¶)  
    - **Adenylase** (è…ºè‹·é…¸åŒ–é…¶)  
    - **Phosphorylase** (ç£·é…¸åŒ–é…¶)  
  - **Amikacin**: å°æŠ—ç´°èŒä»£è¬é…¶å»æ´»åŒ–çš„èƒ½åŠ›æœ€å¼·ã€‚

> [!INFO] è³‡è¨Šæç¤º
> Amikacinåœ¨è‡¨åºŠä¸Šå°æŠ—ä»£è¬é…¶æ”»æ“Šçš„èƒ½åŠ›ç‰¹åˆ¥å¼·ï¼Œé©åˆç”¨æ–¼éœ€è¦æŠ—èŒæ´»æ€§çš„æ²»ç™‚å ´æ™¯ä¸­ã€‚

---

### å”åŒä½œç”¨ï¼šæå‡è—¥ç‰©é€²å…¥ç´°èŒç´°èƒ
- **ä½œç”¨æ©Ÿåˆ¶**: ç•¶ç´°èƒå£åˆæˆæŠ‘åˆ¶åŠ‘å’ŒAminoglycosideä½µç”¨æ™‚ï¼Œå¯ä»¥æå‡è—¥ç‰©é€²å…¥ç´°èŒç´°èƒçš„æ•ˆæœã€‚
  - **å¸¸è¦‹çµ„åˆ**: Penicillins + Streptomycinï¼Œæœ‰æ•ˆæ²»ç™‚è…¸çƒèŒå¿ƒå…§è†œç‚å’Œé‡‘é»ƒè‰²è‘¡è„çƒèŒæ„ŸæŸ“ã€‚
  - **æ›¿ä»£é¸æ“‡**: Gentamycinå·²å¤§éƒ¨åˆ†å–ä»£Streptomycinåœ¨é€™äº›æ‡‰ç”¨ä¸Šçš„åœ°ä½ã€‚

---

### Typical Therapeutic Applications of Aminoglycosides
- å¸¸è¦‹çš„é©æ‡‰ç—‡åŒ…æ‹¬ï¼š
  - **Bå‹éˆçƒèŒæ„ŸæŸ“**
  - **å…”ç†±ç—…** (Francisella tularensis)
  - **é®‘æ›¼ä¸å‹•æ¡¿èŒæ„ŸæŸ“**
  - **å¸ƒé­¯æ°èŒå±¬æ„ŸæŸ“**
  - **é¼ ç–«æ¡¿èŒ (Yersinia pestis)**
  - **æ³Œå°¿é“æ„ŸæŸ“ (UTI)**

> [!NOTE] å”åŒä½œç”¨çš„æ‡‰ç”¨
> å°‡ç´°èƒå£åˆæˆæŠ‘åˆ¶åŠ‘èˆ‡èƒºåŸºé†£è‹·é¡æŠ—ç”Ÿç´ ä½µç”¨ï¼Œå¯ä»¥é¡¯è‘—æå‡è—¥æ•ˆï¼Œå°¤å…¶åœ¨æ²»ç™‚é›£æ²»æ€§æ„ŸæŸ“æ™‚å…·æœ‰é‡è¦è‡¨åºŠæ„ç¾©ã€‚

### Aminoglycosides è—¥ç‰©çš„è—¥ç‰©å‹•åŠ›å­¸åƒæ•¸è¡¨æ ¼

| **Aminoglycoside (èƒºåŸºé†£è‹·é¡)** | **Administration (çµ¦è—¥é€”å¾‘)** | **t 1/2 (åŠè¡°æœŸ, å°æ™‚)** | **Anuric t 1/2 (ç„¡å°¿æ‚£è€…åŠè¡°æœŸ, å°æ™‚)** | **Protein Binding (è›‹ç™½è³ªçµåˆç‡, %)** | **Elimination (æ’æ³„)** |
|--------------------------------|----------------------------|------------------------|-------------------------------|-------------------------------|---------------------|
| Gentamicin (å¥ä»–é»´ç´ )           | IV, IM                     | 2                      | 35-50                         | <10                           | R (100%)            |
| Streptomycin (éˆé»´ç´ )          | IM                         | 2-2.5                  | 35-50                         | 35                            | R (100%)            |
| Kanamycin (å¡é‚£é»´ç´ )           | IV, IM                     | 2-2.5                  | 35-50                         | <10                           | R (100%)            |
| Tobramycin (å¦¥å¸ƒé»´ç´ )          | IV, IM                     | 2                      | 35-50                         | <10                           | R (100%)            |
| Amikacin (é˜¿ç±³å¡æ˜Ÿ)            | IV, IM                     | 2-2.5                  | 35-50                         | <10                           | R (100%)            |
| Netilmicin (å¥ˆæ›¿ç±³æ˜Ÿ)          | IV, IM                     | 2                      | 35-50                         | <10                           | R (100%)            |

#### å‚™è¨»
- ==å®Œå…¨ç„¡å£æœã€å®Œå…¨è…æ’é™¤==
- **Aminoglycosides (èƒºåŸºé†£è‹·é¡)** å…·æœ‰é•·çµ„ç¹”åŠè¡°æœŸ (25è‡³500å°æ™‚)ã€‚
- **è…¸èƒƒé“å¸æ”¶ä¸è‰¯**: ç”±æ–¼ç‚ºé«˜åº¦æ¥µæ€§åŒ–åˆç‰©ï¼Œå› æ­¤é›£ä»¥è¢«è…¸èƒƒé“å¸æ”¶ã€‚
- **è…è‡Ÿæ’æ³„**: ä¸»è¦ç¶“ç”±è…è‡Ÿæ’æ³„ï¼Œæ¸…é™¤ç‡èˆ‡è‚Œé…æ¸…é™¤ç‡æˆæ­£æ¯”ã€‚

> [!INFO] è³‡è¨Šæç¤º
> Aminoglycosides ä¸»è¦ç¶“ç”±è…è‡Ÿæ’æ³„ï¼Œå°æ–¼è…åŠŸèƒ½ä¸å…¨çš„æ‚£è€…éœ€èª¿æ•´åŠ‘é‡ï¼Œä¸¦æ³¨æ„å¯èƒ½çš„è…æ¯’æ€§ã€‚


### Aminoglycosides çš„å‰¯ä½œç”¨èˆ‡è¨˜æ†¶å£è¨£

#### å‰¯ä½œç”¨
1. **Nephrotoxicity (è…æ¯’æ€§)**ï¼š
   - ä¾‹å¦‚ï¼šneomycin, tobramycin, gentamicin
   - åŠ é‡è…æ¯’æ€§çš„è—¥ç‰©åˆä½µä½¿ç”¨ï¼švancomycin æˆ– amphotericin B
   - **TDM (Therapeutic Drug Monitoring, è—¥ç‰©è¡€ä¸­æ¿ƒåº¦ç›£æ¸¬)** éœ€è¦æ³¨æ„
   - **Loop Diuretics (è¢¢åˆ©å°¿åŠ‘)**ï¼šå¦‚ furosemide å’Œ ethacrynic acidï¼Œæœƒå¢åŠ è…æ¯’æ€§

> [!WARNING] æ³¨æ„ âš ï¸ è…æ¯’æ€§
> ä½¿ç”¨ Aminoglycosides æ™‚ï¼Œå°¤å…¶æ˜¯èˆ‡å…¶ä»–å…·è…æ¯’æ€§çš„è—¥ç‰©å¦‚ vancomycinã€loop diuretics åˆä½µï¼Œéœ€è¬¹æ…ç›£æ§è…åŠŸèƒ½ã€‚

2. **Ototoxicity (è€³æ¯’æ€§)**ï¼š
   - è½è¦ºæå®³ï¼šä¾‹å¦‚ neomycin, kanamycin, amikacin
   - å‰åº­æå®³ï¼šstreptomycin å’Œ gentamicin
   - é¿å…èˆ‡ loop diuretics ä½µç”¨ä»¥æ¸›å°‘è€³æ¯’æ€§

> [!NOTE] é‡é» âœï¸ è€³æ¯’æ€§
> æ³¨æ„ Aminoglycosides å°è½è¦ºå’Œå‰åº­çš„å½±éŸ¿ï¼Œèˆ‡ loop diuretics åˆä½µä½¿ç”¨æœƒå¢å¼·æ¯’æ€§ä½œç”¨ã€‚

3. **Neuromuscular Blockade (ç¥ç¶“è‚Œè‚‰é˜»æ–·)**ï¼š
   - é«˜åŠ‘é‡æ™‚å¯èƒ½ç”¢ç”Ÿé¡ä¼¼ d-tubocurarine çš„é˜»æ–·æ•ˆæ‡‰
   - **è§£æ•‘æ–¹å¼**ï¼šå¯ç”¨ calcium gluconate æˆ– neostigmine é€†è½‰

#### è¨˜æ†¶å£è¨£
- **éˆçµ²èŒå±¬ Streptomyces åˆ†é›¢å‡ºä¾†çš„ "-mycin"**ï¼š
  - ä¾‹å¦‚ï¼šKanamycin, Streptomycin
- **å°å–®å­¢èŒå±¬ Micromonospora åˆ†é›¢å‡ºä¾†çš„ "-micin"**ï¼š
  - ä¾‹å¦‚ï¼šGentamicin, Sisomicin, Netilmicin
é€™å¼µåœ–ç‰‡æä¾›äº†Aminoglycosidesçš„ç›¸é—œå£è¨£ï¼Œæœ‰åŠ©æ–¼è¨˜æ†¶é‡è¦è³‡è¨Šå’Œå‰¯ä½œç”¨ï¼Œä»¥ä¸‹ç‚ºè©³ç´°æ•´ç†èˆ‡å£è¨£èªªæ˜ï¼š

### Aminoglycosides å£è¨£ï¼š
- **TANGS**ï¼šç”¨æ–¼è¨˜æ†¶å¸¸è¦‹çš„Aminoglycosides
  - **T**obramycin
  - **A**mikacin
  - **N**eomycin
  - **G**entamicin
  - **S**treptomycin

- **AMINO**ï¼šç”¨æ–¼è¨˜æ†¶Aminoglycosidesçš„ä¸»è¦ä½œç”¨èˆ‡ç‰¹å¾µ
  - **A**gainst aerobic gram-negative bacteria (é‡å°éœ€æ°§æ€§é©è˜­æ°é™°æ€§èŒ)
  - **M**ainly bactericidal (ä¸»è¦ç‚ºæ®ºèŒæ€§)
  - **I**nhibit protein synthesis at the 30S subunit (æŠ‘åˆ¶30Sæ ¸ç³–é«”äºåŸºä¸Šçš„è›‹ç™½è³ªåˆæˆ)
  - **N**ephrotoxic (è…æ¯’æ€§)
  - **O**totoxic (è€³æ¯’æ€§)

- **NANO**ï¼šç”¨æ–¼è¨˜æ†¶å‰¯ä½œç”¨
  - **N**eurotoxicity (ç¥ç¶“æ¯’æ€§)
  - **A**llergic reactions (éæ•åæ‡‰)
  - **N**ephrotoxicity (è…æ¯’æ€§)
  - **O**totoxicity (è€³æ¯’æ€§)

> [!TIP] è¨˜æ†¶å£è¨£ ğŸ”¥
> ä½¿ç”¨å£è¨£ã€ŒTANGSã€ã€ã€ŒAMINOã€èˆ‡ã€ŒNANOã€å¯ä»¥å¿«é€ŸæŒæ¡Aminoglycosidesçš„ç¨®é¡ã€ä½œç”¨æ©Ÿåˆ¶èˆ‡å¸¸è¦‹å‰¯ä½œç”¨ï¼Œæœ‰åŠ©æ–¼å­¸ç¿’å’Œè‡¨åºŠæ‡‰ç”¨ã€‚

#### æ¿ƒåº¦ä¾è³´å‹ vs æ™‚é–“ä¾è³´å‹æŠ—ç”Ÿç´ 
- **æ¿ƒåº¦ä¾è³´å‹ (Concentration-dependent)** æŠ—ç”Ÿç´ å¦‚ Aminoglycosidesã€quinolones
  - ***å¾ŒæŠ—ç”Ÿç´ æ•ˆæ‡‰* (PAE)**ï¼šæŠ‘èŒæ•ˆæœåœ¨æŠ—ç”Ÿç´ æ¿ƒåº¦ä¸‹é™åˆ°æœ€ä½æŠ‘èŒæ¿ƒåº¦ (MBC) ä»¥ä¸‹å¾Œä»èƒ½æŒçºŒæŠ‘åˆ¶ç´°èŒç”Ÿé•·ï¼Œ aminoglycoside å³å…·æœ‰æ­¤æ•ˆæ‡‰
  - æŒ‡æ¨™ï¼šT-C â‰¥ 1.5 å°æ™‚
    - Tï¼šçµ¦äºˆæŠ—ç”Ÿç´ å¾Œ 2 å°æ™‚å†æ´—æ‰ï¼Œç´°èŒå¢é•·è‡³ 10 å€æ‰€éœ€çš„æ™‚é–“
    - Cï¼šæœªçµ¦äºˆæŠ—ç”Ÿç´  2 å°æ™‚å¾Œå†æ´—æ‰ï¼Œç´°èŒå¢é•·è‡³ 10 å€æ‰€éœ€çš„æ™‚é–“

> [!INFO] å–®åŠ‘é‡ vs åˆ†åŠ‘é‡ç™‚æ³•
> Aminoglycosides å¯æ¡ç”¨ä¸€æ¬¡æ€§å¤§åŠ‘é‡çµ¦è—¥ (once-daily dosing)ï¼Œå¯æ¸›å°‘å‰¯ä½œç”¨ä¸¦æå‡ç™‚æ•ˆã€‚

- **æ™‚é–“ä¾è³´å‹ (Time-dependent)** æŠ—ç”Ÿç´ å¦‚ Î²-lactams å’Œ Vancomycinï¼Œéœ€é•·æ™‚é–“ä¿æŒæœ‰æ•ˆæ¿ƒåº¦ä»¥é”åˆ°æŠ‘èŒæ•ˆæœã€‚

# Tetracyclines å››ç’°é»´ç´ é¡ (30S)

- **ä½œç”¨æ©Ÿåˆ¶**
  - çµåˆ 30S æ ¸ç³–é«” RNAï¼Œç›´æ¥é˜»ç¤™ aminoacyl-tRNA é™„è‘—åœ¨ A ä½é»ï¼Œæ¸›å°‘èƒºåŸºé…¸çš„æ·»åŠ åˆ°ç”Ÿé•·ä¸­çš„è‚½éˆã€‚å¥½ç”¨åˆä¾¿å®œ
	- ä½”A side
- **åˆ†é¡**
  - çŸ­æ•ˆå‹ï¼šæ°¯å››ç’°ç´  (Chlortetracycline)ã€åœŸéœ‰ç´  (Oxytetracycline)ã€å››ç’°ç´  (Tetracycline)
  - ä¸­æ•ˆå‹ï¼šåœ°ç¾ç’°ç´  (Demeclocycline)ã€ç”²ç’°ç´  (Methacycline)
  - é•·æ•ˆå‹ï¼šå¤šè¥¿ç’°ç´  (Doxycycline)ã€ç±³è«¾ç’°ç´  (Minocycline)ã€æ›¿åŠ ç’°ç´  (Tigecycline)



- **æŠ—èŒç¯„åœ**
  - å»£è­œæŠ—èŒç¯„åœï¼Œå°å¥½æ°§å’Œå­æ°§ G (+) å’Œ G (-) ç´°èŒä»¥åŠå…¶ä»–å¾®ç”Ÿç‰©å¦‚==ç«‹å…‹æ¬¡é«”==(é¦–é¸ç”¨è—¥) ã€æŠ«è¡£èŒã€é»´æ¼¿èŒå’ŒæŸäº›åŸèŸ²**ï¼ˆä¾‹å¦‚é˜¿ç±³å·´åŸèŸ²ï¼‰**æœ‰æ•ˆã€‚
  - ä¾‹å­åŒ…æ‹¬ï¼šè‚ºç‚é»´æ¼¿èŒ (Mycoplasma pneumoniae)ã€**å¹½é–€èºæ—‹æ¡¿èŒ (Helicobacter pylori)**ã€éœäº‚å¼§èŒ (Vibrio cholerae)ã€èŠå§†ç—… (Lyme disease)ã€æŠ«è¡£èŒæ„ŸæŸ“ (Chlamydia infections) ç­‰ã€‚

#### å…¶ä»–ç”¨é€” - æ„Ÿè¦ºå¾ˆé‡è¦
- **èˆ‡ Gentamicin è¯åˆä½¿ç”¨** å¯å°æŸäº›æ„ŸæŸ“ç”¢ç”Ÿå”åŒä½œç”¨ã€‚
- metronidazole + tetracycline + PPI å¯ä»¥æ²»ç™‚æ¶ˆåŒ–æ€§æ½°ç˜(Peptic glcer disease)
- Doxycycline æ²»è¢«èœ±èŸ²å’¬çš„èŠå§†ç—…(Lyme disease)
- macrolide æˆ–æ˜¯ doxycycline æ²»è‚ºç‚é»´æ¼¿èŒ(Mycoplasma Pneumoniae)
- Doxycycline å¯ä»¥æ²»éœäº‚
- Doxycycline æˆ– Azithromycin ç”¨æ–¼æ²»ç™‚ç ‚çœ¼æŠ«è¡£èŒæ„ŸæŸ“(Chlamydial infections)
- tetracycline é é˜²ç”±ç«‹å…‹æ¬¡é«”(Rickettsia)å‚³æ’­çš„ç–¾ç—…å¦‚æ´›ç£¯å±±ç–¹ç†±
---




---

### å››ç’°ç´ é¡çš„è—¥å‹•å­¸åƒæ•¸

| å››ç’°ç´ é¡è—¥ç‰©                            | çµ¦è—¥é€”å¾‘            | å¸æ”¶ç‡ (%) | åŠè¡°æœŸ (å°æ™‚) | è…åŠŸèƒ½ä¸å…¨æ‚£è€…åŠè¡°æœŸ (å°æ™‚) | è›‹ç™½çµåˆç‡ (%) | æ’æ³„æ–¹å¼              |
| --------------------------------- | --------------- | ------- | -------- | --------------- | --------- | ----------------- |
| å››ç’°ç´  (Tetracycline)<br>*çœ¼è—¥è†å¤–ç”¨*     | å£æœã€éœè„ˆæ³¨å°„ã€è‚Œè‚‰æ³¨å°„ã€å¤–ç”¨ | 55      | 8(çŸ­)     | >50             | 55        | ä»£è¬ã€è…è‡Ÿæ’æ³„           |
| å¤šè¥¿ç’°ç´  (Doxycycline)<br>*åœ¨è‚ç•°å¸¸ä¸‹å”¯ä¸€å¯ç”¨* | å£æœã€éœè„ˆæ³¨å°„         | 85      | 16       | 20-30           | 85        | ä»£è¬ã€**è…è‡Ÿ**ã€è†½é“æ’æ³„    |
| åœŸéœ‰ç´  (Oxytetracycline)             | å£æœã€è‚Œè‚‰æ³¨å°„         | 30      | 9        | é•·æ•ˆ              | 30        | ä»£è¬ã€è…è‡Ÿ (20-30%)    |
| ç±³è«¾ç’°ç´  (Minocycline)                | å£æœã€éœè„ˆæ³¨å°„         | 75      | 16       | 20-30           | 75        | ä»£è¬ã€è…è‡Ÿ (5%)        |
| æ°¯å››ç’°ç´  (Chlortetracycline)          | å£æœ              | 50      | 6        | >50             | 50        | ä»£è¬ã€è…è‡Ÿæ’æ³„           |
| æ›¿åŠ ç’°ç´  (Tigecycline)<br>*åŠè¡°æœŸæœ€é•·*     | éœè„ˆæ³¨å°„            | -       | 27       | ç„¡è®ŠåŒ–             | -         | èƒ†é“ (59%)ã€è…è‡Ÿ (22%) |

> [!NOTE] ä½¿ç”¨æ³¨æ„äº‹é …
> 1. å£æœå¸æ”¶ç‚ºä¸»ï¼šå¤šè¥¿ç’°ç´  (Doxycycline) å’Œç±³è«¾ç’°ç´  (Minocycline) çš„å¸æ”¶ä¸å—é£Ÿç‰©å¹²æ“¾ã€‚
> 2. æœƒèˆ‡é‡é‡‘å±¬é›¢å­å½¢æˆè¯åˆç‰©ï¼Œå°è‡´ CaÂ²âº, MgÂ²âº, AlÂ³âº, FeÂ²âº å¤±å»ä½œç”¨ï¼Œé™ä½å¸æ”¶æ•ˆç‡ã€‚å› æ­¤ï¼Œæœç”¨**æŠ—é…¸åŠ‘ã€ç‰›å¥¶æˆ–å«éµè£½åŠ‘æœƒå½±éŸ¿å¸æ”¶ã€‚**
> 3. æœƒå½±éŸ¿éˆ£åŒ–çµ„ç¹”ï¼ˆå¦‚ç‰™é½’å’Œéª¨éª¼ï¼‰ï¼Œå­•å©¦åŠ 8 æ­²ä»¥ä¸‹å…’ç«¥ç¦ç”¨ã€‚


### Adverse Reactions of Tetracyclines å››ç’°é»´ç´ é¡çš„å‰¯ä½œç”¨

- **è…¸èƒƒé“ä¸é© (GI)**ï¼šå››ç’°é»´ç´ å¯èƒ½å¼•èµ·å™å¿ƒã€å˜”åã€è…¹ç€‰ç­‰èƒƒè…¸é“ä¸è‰¯åæ‡‰ã€‚
- **è‚åŠŸèƒ½å—æ (Liver Failure)**ï¼šé•·æœŸæˆ–éé‡ä½¿ç”¨å››ç’°é»´ç´ é¡è—¥ç‰©å¯èƒ½å°è‡´è‚è‡Ÿæ¯’æ€§åæ‡‰ï¼Œç‚ºæœ€åš´é‡ä¹‹å‰¯ä½œç”¨ã€‚
- **é ­æšˆèˆ‡çœ©æšˆ (Vertigo)**ï¼šç‰¹åˆ¥æ˜¯==ç±³è«¾ç’°ç´  (Minocycline) å’Œå¤šè¥¿ç’°ç´  (Doxycycline)== ä½¿ç”¨è€…æ›´å®¹æ˜“ç”¢ç”Ÿä¸­æ¨ç¥ç¶“ç³»çµ±çš„å‰¯ä½œç”¨ï¼Œå¦‚é ­æšˆå’Œçœ©æšˆã€‚
- **è—¥ç‰©åœ¨ç‰™é½’å’Œéª¨éª¼ä¸­çš„æ²‰ç© (Deposition in Teeth and Bones)**ï¼šå¯èƒ½å½±éŸ¿ç‰™é½’çš„ç™¼è‚²ï¼Œå°¤å…¶æ˜¯åœ¨å­•å©¦åŠå…’ç«¥ä½¿ç”¨æ™‚ï¼Œæ‡‰é¿å…å››ç’°é»´ç´ é¡è—¥ç‰©ã€‚
- **å…‰æ•æ€§ (Phototoxicity)**ï¼š==åœ°ç¾ç’°ç´  (Demeclocycline) å’Œå¤šè¥¿ç’°ç´  (Doxycycline)== ä½¿ç”¨è€…åœ¨æ¥è§¸é™½å…‰å¾Œå¯èƒ½æœƒå¼•ç™¼å…‰æ•æ€§åæ‡‰ã€‚
- **å­•æœŸä½¿ç”¨æ‡‰é¿å… (Avoid in Pregnancy)**ï¼šå››ç’°é»´ç´ é¡è—¥ç‰©å¯èƒ½å°èƒå…’ç™¼è‚²é€ æˆä¸è‰¯å½±éŸ¿ï¼Œç‰¹åˆ¥æ˜¯ç‰™é½’å’Œéª¨éª¼çš„ç™¼è‚²ã€‚å¦‚ ==Demeclocycline==

> [!NOTE] å››ç’°é»´ç´ é¡è—¥ç‰©çš„æŠ—è—¥æ€§æ©Ÿåˆ¶
> - ç´°èŒå°å››ç’°é»´ç´ çš„æŠ—è—¥æ€§ä¸»è¦é€šé**æ’æ”¾æ³µ (Efflux Pump)** è¡¨ç¾ï¼Œé€™äº›æ³µå°‡å››ç’°é»´ç´ æ’å‡ºç´°èŒç´°èƒï¼Œä½¿è—¥æ•ˆé™ä½ã€‚
> - å…·æœ‰ Tet æ’æ”¾æ³µçš„é©è˜­æ°é™°æ€§èŒç¨®é€šå¸¸å°è¼ƒèˆŠçš„å››ç’°é»´ç´ ã€å¤šè¥¿ç’°ç´ å’Œç±³è«¾ç’°ç´ å…·æœ‰æŠ—è—¥æ€§ï¼Œä½†å°**æ›¿åŠ ç’°ç´  (Tigecycline)** ä»ç„¶æ•æ„Ÿã€‚
### å››ç’°é»´ç´ æŠ—è—¥æ€§

- **Tet æ’æ”¾æ³µ (Tet Efflux Pump)**ï¼šé©è˜­æ°é™°æ€§èŒ (G-) ç”¨æ’æ”¾æ³µå°‡å››ç’°é»´ç´ æ’å‡ºç´°èŒç´°èƒå¤–ï¼Œé€²è€Œå½±éŸ¿å…¶æŠ—èŒä½œç”¨ã€‚ä½†==æ›¿åŠ ç’°ç´  (Tigecycline)== å°æ–¼é€™äº›è€è—¥èŒç¨®ä»ç„¶æœ‰æ•ˆã€‚
# Macrolides å·¨ç’°é¡ (50S)

#### **Erythromycin (ç´…é»´ç´ ) æ©Ÿåˆ¶èˆ‡ä½œç”¨æ©Ÿè½‰**
- **ä½œç”¨æ©Ÿåˆ¶**ï¼š**çµåˆæ–¼ç´°èŒ 50S æ ¸ç³–é«”äºåŸº**ï¼ŒæŠ‘åˆ¶èµ·å§‹è¤‡åˆç‰©çš„å½¢æˆèˆ‡èƒºé†¯è½‰ä½åæ‡‰ï¼Œæ¸›å°‘è‚½è½‰ç§»é…¶ (peptidyl transferase) çš„æ´»æ€§ï¼Œé˜»æ–· peptide bond çš„å½¢æˆã€‚
- **æŠ—èŒæ´»æ€§**ï¼š
  - ä¸»è¦é‡å° G (+) èŒç¨®ï¼Œä¾‹å¦‚ï¼šè‚ºç‚çƒèŒã€é‡‘é»ƒè‰²è‘¡è„çƒèŒã€éˆçƒèŒå’Œç™½å–‰æ¡¿èŒ (Corynebacterium diphtheriae)ã€‚
  - é»´æ¼¿èŒ (Mycoplasma)(å·²ç¶“å…·æœ‰æŠ—è—¥æ€§) ã€**é€€ä¼è»äººèŒ (Legionella)ã€ç ‚çœ¼æŠ«è¡£èŒ (Chlamydia trachomatis)** ä¹Ÿå…·æœ‰æ•æ„Ÿæ€§ã€‚
  - ==ç”¨æ–¼ç¤¾å€æ€§è‚ºç‚æ²»ç™‚==

#### **Clarithromycin (å…‹æ‹‰é»´ç´ ) çš„æ¯”è¼ƒ**
- ç›¸è¼ƒæ–¼ç´…é»´ç´ ï¼š
  - å…·æœ‰æ›´ä½³çš„è€é…¸æ€§èˆ‡å£æœå¸æ”¶ç‡ã€‚
  - è…¸èƒƒä¸é©åæ‡‰è¼ƒå°‘ï¼Œæœç”¨é »æ¬¡æ¸›å°‘ã€‚
  - ä¹Ÿ**å½±éŸ¿ CYP450 é…µç´ **ã€‚

#### **Azithromycin (é˜¿å¥‡é»´ç´ ) çš„ç‰¹é»**
- å’Œç´…é»´ç´ ã€å…‹æ‹‰é»´ç´ ä¸»è¦åœ¨è—¥å‹•å­¸æ–¹é¢ä¸åŒï¼š
  - ç©¿é€å¤§éƒ¨åˆ†çµ„ç¹” (ä½†ä¸åŒ…æ‹¬è…¦è„Šæ¶²)ã€‚
  - åŠè¡°æœŸæœ€é•· (æ¯æ—¥ä¸€æ¬¡åŠ‘é‡)ã€‚
  - **==ä¸==å½±éŸ¿ CYP450**ã€‚

#### **Ketolides**
- ä»£è¡¨è—¥ç‰©ï¼šTelithromycinã€Solithromycinã€‚
- ç”¨æ–¼ç¤¾å€æ€§è‚ºç‚æ²»ç™‚ã€‚
- æŠ‘åˆ¶ CYP450 ä¸¦å¯å»¶é•· QTc é–“æœŸï¼Œåš´é‡è‚è¡°ç«­é¢¨éšª**å·²ä¸‹æ¶**ã€‚



---

#### **è¡¨æ ¼ï¼šMacrolides ç›¸é—œæ¯”è¼ƒ** - å¥½ç”¨

| è—¥ç‰©åç¨±               | ä¸»è¦ç‰¹é»                     | CYP450 å½±éŸ¿  |
| ------------------ | ------------------------ | ---------- |
| **Erythromycin**   | å»£æ•ˆ G (+) æŠ—èŒã€ä¸»è¦ç”¨æ–¼ç¤¾å€æ€§è‚ºç‚ç­‰æ„ŸæŸ“ | å½±éŸ¿ CYP450  |
| **Clarithromycin** | æ”¹å–„é…¸ç©©å®šæ€§ã€å£æœå¸æ”¶ä½³ã€è¼ƒå°‘è…¸èƒƒä¸é©      | å½±éŸ¿ CYP450  |
| **Azithromycin**   | åŠè¡°æœŸé•·ã€æ¯æ—¥ä¸€æ¬¡åŠ‘é‡ã€ä¸å½±éŸ¿ CYP450   | ä¸å½±éŸ¿ CYP450 |
| **Telithromycin**  | ç”¨æ–¼ç¤¾å€æ€§è‚ºç‚ï¼Œå½±éŸ¿ QTc é–“æœŸ (ä¸‹æ¶)   | å½±éŸ¿ CYP450  |

# Chloramphenicol æ°¯é»´ç´  (50S)

### Lincosamides é¡æŠ—ç”Ÿç´ ï¼šClindamycin, Lincomycin

#### **ä½œç”¨æ©Ÿåˆ¶**
- **çµåˆä½ç½®**ï¼šClindamycin çš„çµåˆä½ç½®åœ¨ç´°èŒ 50S æ ¸ç³–é«”äºåŸºä¸Šï¼Œèˆ‡ç´…é»´ç´ ç›¸åŒã€‚

#### **æŠ—èŒæ´»æ€§**
- ä¸»è¦å°é©è˜­æ°é™½æ€§èŒ (G+) å¦‚éˆçƒèŒã€è‘¡è„çƒèŒã€è‚ºç‚çƒèŒæœ‰æ•ˆï¼Œå°è…¸çƒèŒèˆ‡é©è˜­æ°é™°æ€§éœ€æ°§èŒå‰‡ç„¡æ•ˆã€‚å°æ“¬æ¡¿èŒå±¬ (Bacteroides) åŠå…¶ä»–å­æ°§èŒé€šå¸¸æœ‰æ•ˆã€‚
- **è‡¨åºŠé©æ‡‰ç—‡**ï¼šæ²»ç™‚ç”±éˆçƒèŒå’Œè‘¡è„çƒèŒå¼•èµ·çš„çš®è†šèˆ‡è»Ÿçµ„ç¹”æ„ŸæŸ“ã€‚==å¸¸èˆ‡Î²-lactamé¡æŠ—ç”Ÿç´ ä½µç”¨ä»¥æ²»ç™‚ä¸­æ¯’æ€§ä¼‘å…‹ç¶œåˆå¾µæˆ–å£æ­»æ€§ç­‹è†œç‚ã€‚==




#### **å‰¯ä½œç”¨**
- **æŠ—ç”Ÿç´ ç›¸é—œæ€§è…¹ç€‰ (AAD)**ï¼šé•·æœŸæœç”¨æŠ—ç”Ÿç´  (å¦‚å»£æ•ˆå‹æŠ—ç”Ÿç´ ã€é ­å­¢èŒç´ ã€Clindamycinã€æ°Ÿå–¹è«¾é…®é¡) å¼•èµ·ï¼Œå°‘æ•¸ç—…äººå› æ­£å¸¸èŒå¢è¢«ç ´å£ï¼Œå°è‡´**ç—…åŸèŒ (å¦‚å›°é›£æ¢­ç‹€æ¡¿èŒ C. difficile) éåº¦å¢ç”Ÿï¼Œå¼•ç™¼å½è†œæ€§è…¸ç‚ç­‰åš´é‡ç—‡ç‹€ã€‚**

> [!WARNING] **C. difficile æ²»ç™‚æªæ–½**
> - åœç”¨ä¸å¿…è¦çš„æŠ—ç”Ÿç´ ï¼Œä¸¦çµ¦äºˆé©ç•¶çš„æŠ—ç”Ÿç´ æ²»ç™‚ï¼Œ==é¦–é¸è—¥ç‰©ç‚º Metronidazoleã€å£æœ Vancomycin åŠå£æœ Fidaxomicin (å·¨ç’°é¡)(æ–°è—¥) ã€‚==

---

### **Streptogramins: Quinupristin/dalfopristin**

- **é…æ¯”**ï¼šä»¥ 30:70 çš„æ¯”ä¾‹çµåˆã€‚
- **çµåˆä½ç½®**ï¼šå…©è€…çµåˆè‡³ 50S æ ¸ç³–é«”äºåŸºï¼ŒQuinupristin èˆ‡å·¨ç’°é¡è—¥ç‰©çµåˆè‡³ç›¸åŒä½ç½®ï¼Œä½¿è‚½éˆ tRNA å¾æ ¸ç³–é«”ä¸Šè„«é›¢ï¼Œå°è‡´è‚½éˆå»¶ä¼¸æ—©æœŸçµ‚æ­¢ï¼›Dalfopristin æœƒå¼•ç™¼æ ¸ç³–é«”æ§‹è±¡æ”¹è®Šï¼Œå¢å¼· Quinupristin çš„çµåˆèƒ½åŠ› 100 å€ã€‚(çµåˆåº¦ä¸Šå‡)

#### **é©æ‡‰ç—‡**
- å°æ‰€æœ‰è‘¡è„çƒèŒã€å¤šé‡è€è—¥éˆçƒèŒã€è€é’é»´ç´ è‚ºç‚éˆçƒèŒåŠå±è…¸çƒèŒ (E. faecium) æœ‰æ•ˆï¼Œä½†å°ç³è…¸çƒèŒ (Enterococcus faecalis) ç„¡æ•ˆã€‚


---


| é¡åˆ¥             | ç‰¹æ€§èˆ‡é©æ‡‰ç—‡                                               | ä¸»è¦å‰¯ä½œç”¨                                  |
|------------------|----------------------------------------------------------|------------------------------------------|
| **Lincosamides** | ä¸»è¦é‡å°é©è˜­æ°é™½æ€§èŒèˆ‡å­æ°§èŒï¼Œæ²»ç™‚çš®è†šåŠè»Ÿçµ„ç¹”æ„ŸæŸ“ç­‰  | å½è†œæ€§è…¸ç‚ã€è…¸èƒƒé“ä¸é©ã€è‚åŠŸèƒ½æå®³       |
| **Streptogramins** | é‡å°å¤šé‡è€è—¥é©è˜­æ°é™½æ€§èŒï¼Œæ²»ç™‚éå…¸å‹è‚ºç‚ç­‰æ„ŸæŸ“        | è‚æ¯’æ€§ã€éœè„ˆæ³¨å°„éƒ¨ä½åæ‡‰                   |
### Chloramphenicol æ°¯é»´ç´ 

#### **ä½œç”¨æ©Ÿåˆ¶**
- çµåˆè‡³ç´°èŒ 50S æ ¸ç³–é«”äºåŸºã€‚

#### **æŠ—èŒç¯„åœ**
- **å»£æ•ˆå‹æŠ—èŒæ´»æ€§ï¼Œå°å¥½æ°§å’Œå­æ°§çš„é©è˜­æ°é™½æ€§èŒèˆ‡é©è˜­æ°é™°æ€§èŒã€ç«‹å…‹æ¬¡é«”ç­‰æœ‰æ•ˆã€‚**
- å…·åš´é‡çš„å‰¯ä½œç”¨ï¼Œæ‡‰åƒ…åœ¨ç„¡å…¶ä»–é©åˆè—¥ç‰©æ™‚ä½¿ç”¨ï¼Œç¾å¤šç”¨æ–¼çœ¼è—¥æ°´ã€‚



#### **è—¥ä»£å‹•åŠ›å­¸**
- åˆ†å¸ƒå»£æ³›ï¼ŒåŒ…æ‹¬ä¸­æ¨ç¥ç¶“ç³»çµ±å’Œè…¦è„Šæ¶² (CSF)ï¼Œè„‚æº¶æ€§é«˜ã€‚
- ç¶“è‚è‡Ÿè‘¡è„ç³–é†›é…¸åŒ–ä»£è¬ï¼Œåªæœ‰è‚ã€‚

#### **å‰¯ä½œç”¨**
- **è¡€æ¶²æ¯’æ€§**ï¼š**éª¨é«“æŠ‘åˆ¶** `>` ç™½è¡€çƒæ¸›å°‘ç—‡ã€è¡€å°æ¿æ¸›å°‘ç—‡ã€å†ç”Ÿä¸è‰¯æ€§è²§è¡€ç­‰ã€‚
- **ç°å¬°ç—‡**ï¼šå¬°å…’å¯èƒ½å‡ºç¾å‘¼å¸æŠ‘åˆ¶ã€å¿ƒè¡€ç®¡å´©æ½°å’Œçš®è†šç™¼ç°ç­‰ç—‡ç‹€ã€‚
- **è—¥ç‰©äº¤äº’ä½œç”¨**ï¼šæŠ‘åˆ¶è‚è‡Ÿç´°èƒè‰²ç´  P450 é…µç´ ç³»çµ±ï¼›**èˆ‡æ®ºèŒæ€§è—¥ç‰© (å¦‚è¬å¤é»´ç´ å’Œ Î²-å…§é†¯èƒºé¡) äº’ç›¸æ‹®æŠ—ã€‚**(ä¸æ˜)
- **è…¸é“å¿µç èŒå¢ç”Ÿ**ï¼šå¯èƒ½å°è‡´èƒƒè…¸é“å¿µç èŒéåº¦å¢ç”Ÿã€‚

> [!WARNING] **ç°å¬°ç—‡ (Gray Baby Syndrome)**
> å› å¬°å…’ç¼ºä¹ UDP è‘¡è„ç³–é†›é…¸è½‰ç§»é…¶ï¼Œç„¡æ³•ä»£è¬æ°¯é»´ç´ ï¼Œå°è‡´å‘¼å¸æŠ‘åˆ¶ã€å¿ƒè¡€ç®¡è¡°ç«­ã€çš®è†šç™¼ç´ºã€‚(å› ç‚ºé¡è‰²å‘ˆç°ç´«è‰²æ•…ç¨±)

---

### **Oxazolidinones: Linezolid**

#### **ä½œç”¨æ©Ÿåˆ¶**
- ==é˜»æ­¢ 70S æ ¸ç³–é«”è¤‡åˆç‰©çš„å½¢æˆ==(å³æ•´å€‹æ ¸é†£é«”)

#### **æŠ—èŒæ´»æ€§**
- å°é©è˜­æ°é™½æ€§èŒï¼ŒåŒ…æ‹¬è‘¡è„çƒèŒã€éˆçƒèŒã€è…¸çƒèŒã€å­æ°§çƒèŒå’Œæ¡¿èŒå…·æœ‰æ´»æ€§ã€‚
- æ ¸å‡†ç”¨æ–¼æ²»ç™‚è€è¬å¤é»´ç´ è…¸çƒèŒ (VRE) æ„ŸæŸ“ã€é†«ç™‚ç›¸é—œæ€§è‚ºç‚å’Œç¤¾å€æ€§è‚ºç‚ã€‚

#### **å‰¯ä½œç”¨**
- **è¡€æ¶²æ¯’æ€§**ï¼šé•·æœŸä½¿ç”¨å¯èƒ½å¼•èµ·éª¨é«“æŠ‘åˆ¶ï¼ŒåŒ…æ‹¬è²§è¡€ã€ç™½è¡€çƒæ¸›å°‘å’Œè¡€å°æ¿æ¸›å°‘ã€‚
- ä»£è¬æ€§é…¸ä¸­æ¯’
---

#### è¡¨æ ¼ï¼šå¸¸è¦‹æŠ—ç”Ÿç´ çš„è—¥ä»£å‹•åŠ›å­¸åƒæ•¸

| æŠ—ç”Ÿç´                  | çµ¦è—¥æ–¹å¼       | å¸æ”¶       | åŠè¡°æœŸ (hrs) | è›‹ç™½çµåˆç‡ (%) | æ’é™¤é€”å¾‘        |
| ------------------- | ---------- | -------- | --------- | --------- | ----------- |
| **Erythromycin**    | å£æœ, IV     | è‰¯å¥½ï¼Œä½†è®Šç•°æ€§å¤§ | 1.5       | <70       | ä»£è¬ (90%), è… |
| **Azithromycin**    | å£æœ, IV     | è‰¯å¥½       | *10-50*   | 7-50      | è†½æ±          |
| **Clarithromycin**  | å£æœ         | è‰¯å¥½       | 4         | -         | è†½æ±, è… > 50% |
| **Clindamycin**     | å£æœ, IV, IM | 90%      | 2.4       | 90        | ä»£è¬ (90%), è… |
| **Chloramphenicol** | å£æœ, IV     | è‰¯å¥½       | 3         | 50        | ä»£è¬ (90%), è… |
| **Linezolid**       | å£æœ, IV     | 100%     | 4.5-5.5   | 31        | ä»£è¬, è…       |

> [!TIP] **çµ¦è—¥èˆ‡å¸æ”¶**
> Doxycycline å’Œ Minocycline å£æœå¸æ”¶ä¸å—é£Ÿç‰©å½±éŸ¿ï¼Œè€Œ Chloramphenicol å…·æœ‰è‰¯å¥½çš„ CNS ç©¿é€æ€§ã€‚

# è¤‡ç¿’ç”¨å¤§è¡¨

| Category (åˆ†é¡)                                                       | Example(s) (ç¯„ä¾‹)                                                                                                                                  | Ribosomal Target (æ ¸ç³–é«”ç›®æ¨™) |
| ------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------ | ------------------------ |
| **Aminoglycosides [Initiation]** (èƒºåŸºç³–è‹·é¡ [èµ·å§‹])<br>QDçµ¦è—¥(æ¯æ—¥æœç”¨ä¸€æ¬¡)ï¼›å¾Œç·šæŠ—ç”Ÿç´  | Streptomycin (éˆé»´ç´ ), Neomycin (æ–°é»´ç´ ), Kanamycin (å¡é‚£é»´ç´ ), Amikacin (é˜¿ç±³å¡æ˜Ÿ), Gentamicin (æ…¶å¤§é»´ç´ ), Tobramycin (å¦¥å¸ƒé»´ç´ ), Sisomicin (çµ²å¤šé»´ç´ ), Netilmicin (å¥ˆæ›¿ç±³æ˜Ÿ) | 30S                      |
| **Tetracyclines [tRNA binding]** (å››ç’°ç´ é¡ [tRNA çµåˆ])                   | Short-acting (çŸ­æ•ˆ): Chlortetracycline (æ°¯å››ç’°ç´ ), Oxytetracycline (åœŸé»´ç´ ), Tetracycline (å››ç’°ç´ )è¼ƒç‚ºå°‘ç”¨                                                       | 30S                      |
|                                                                     | Intermediate (ä¸­æ•ˆ): Demeclocycline (åœ°ç¾ç’°ç´ ), Methacycline (ç”²çƒ¯å››ç’°ç´ )                                                                                   |                          |
|                                                                     | Long-acting (é•·æ•ˆ): **Doxycycline (å¤šè¥¿ç’°ç´ ), Minocycline (ç±³è«¾ç’°ç´ ), Tigecycline (æ›¿åŠ ç’°ç´ )**                                                                 |                          |
| **Macrolides [Transpeptidation/translocation]** (å·¨ç’°é¡ [è‚½åŸºè½‰ç§»/è½‰ä½])     | Erythromycin (ç´…é»´ç´ ), Clarithromycin (å…‹æ‹‰é»´ç´ ), Azithromycin (é˜¿å¥‡é»´ç´ )                                                                                   | 50S                      |
| **Lincosamides** (æ—å¯é…°èƒºé¡)                                            | Clindamycin (å…‹æ—é»´ç´ ), Lincomycin (æ—å¯é»´ç´ )                                                                                                            | 50S                      |
| **Ketolides** (é…®å…§é…¯é¡)                                                | Telithromycin (æ³°åˆ©éœ‰ç´ ), Solithromycin (ç´¢åˆ©éœ‰ç´ )                                                                                                       | 50S                      |
| **Streptogramins** (éˆçµ²èŒç´ é¡)                                          | Quinupristin/dalfopristin (å¥å¥´æ™®ä¸/é”ç¦æ™®ä¸)                                                                                                            | 50S                      |
| **Chloramphenicol [Peptidyl transferase]** (æ°¯é»´ç´  [è‚½åŸºè½‰ç§»é…¶])            | Chloramphenicol (æ°¯é»´ç´ )                                                                                                                            | 50S                      |
| **Oxazolidinones [Initiation]** (æƒ¡å”‘çƒ·é…®é¡ [èµ·å§‹])                        | Linezolid (åˆ©å¥ˆå”‘èƒº)                                                                                                                                 | 70S                      |